Presentation of IFN-γ to nitric oxide-producing cells:: A novel function for mast cells

被引:33
作者
Brooks, B
Briggs, DM
Eastmond, NC
Fernig, DG
Coleman, JW [1 ]
机构
[1] Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3GE, Merseyside, England
[2] Univ Liverpool, Sch Biol Sci, Liverpool L69 3GE, Merseyside, England
关键词
D O I
10.4049/jimmunol.164.2.573
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We report that mast cells can bind and present IFN-gamma in a functionally active form to macrophages. Flow-cytometric analysis revealed that biotinylated IFN-gamma bound equally well to purified peritoneal mast cells from both IFN-gamma R knockout and wild-type mice, indicating a non-IFN-gamma R binding site. Purified peritoneal mast cells, loaded with IFN-gamma for 30 min and washed, were able to induce NO synthesis by peritoneal macrophages. This response required cell contact and expression of IFN-gamma R on the responding macrophages, but not the mast cells. Human HMC-1 mast cells were also able to present IFN-gamma to mouse macrophages. Enzyme treatment of mouse mast cells revealed that binding of IFN-gamma was predominantly to chondroitin sulfate B (dermatan sulfate). Binding of IFN-gamma to dermatan sulfate was confirmed by inhibition ELISA. This study demonstrates for the first time that mast cells can present IFN-gamma to other cells via glycosaminoglycans. Mast cells may act as a reservoir of surface-stored functionally active cytokines.
引用
收藏
页码:573 / 579
页数:7
相关论文
共 50 条
[11]   HEPARIN INHIBITS THE ANTIPARASITIC AND IMMUNE MODULATORY EFFECTS OF HUMAN RECOMBINANT INTERFERON-GAMMA [J].
DAUBENER, W ;
NOCKEMANN, S ;
GUTSCHE, M ;
HADDING, U .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (03) :688-692
[12]  
Deschoolmeester ML, 1999, IMMUNOLOGY, V96, P138
[13]  
DING AH, 1988, J IMMUNOL, V141, P2407
[14]   Examination of the mechanism by which heparin antagonizes activation of a model endothelium by interferon-gamma (IFN-gamma) [J].
Douglas, MS ;
Rix, DA ;
Dark, JH ;
Talbot, D ;
Kirby, JA .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 107 (03) :578-584
[15]  
Eastmond NC, 1997, J IMMUNOL, V159, P1444
[16]   THE MOLECULAR CELL BIOLOGY OF INTERFERON-GAMMA AND ITS RECEPTOR [J].
FARRAR, MA ;
SCHREIBER, RD .
ANNUAL REVIEW OF IMMUNOLOGY, 1993, 11 :571-611
[17]   Binding of interferon γ by glycosaminoglycans:: A strategy for localization and or inhibition of its activity [J].
Fernandez-Botran, R ;
Yan, J ;
Justus, DE .
CYTOKINE, 1999, 11 (05) :313-325
[18]  
Fernig David G., 1994, Progress in Growth Factor Research, V5, P353, DOI 10.1016/0955-2235(94)00007-8
[19]   COMPARTMENTALIZATION OF A HEMATOPOIETIC GROWTH-FACTOR (GM-CSF) BY GLYCOSAMINOGLYCANS IN THE BONE-MARROW MICROENVIRONMENT [J].
GORDON, MY ;
RILEY, GP ;
WATT, SM ;
GREAVES, MF .
NATURE, 1987, 326 (6111) :403-405
[20]   ANALYSIS OF NITRATE, NITRITE, AND [N-15]-LABELED NITRATE IN BIOLOGICAL-FLUIDS [J].
GREEN, LC ;
WAGNER, DA ;
GLOGOWSKI, J ;
SKIPPER, PL ;
WISHNOK, JS ;
TANNENBAUM, SR .
ANALYTICAL BIOCHEMISTRY, 1982, 126 (01) :131-138